Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
817 studies found for:    "Hypertension, Pulmonary"
Show Display Options
Download search resultsDownload the search results for:
"Hypertension, Pulmonary" (817 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Unknown  Simvatstatin Used to Treat Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: simvastatin
2 Completed Observation of Patients With Primary Pulmonary Hypertension Receiving Prescribed Ventavis Inhalation Therapy Regarding Safety and Efficacy for up to 4 Years
Condition: Hypertension, Pulmonary
Intervention: Drug: Iloprost (Ventavis, BAYQ6256)
3 Completed An Open Multiple Dose Titration Study In Patients With Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: Riociguat (Adempas, BAY63-2521)
4 Completed Aerobic Exercise in Patients With Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Interventions: Procedure: Excerise Training;   Procedure: Patient Education (Placebo)
5 Recruiting Effect of Exercise Training in Patients With Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Interventions: Behavioral: respiratory and exercise therapy;   Behavioral: respiratory and exercise therapy with supplemental oxygen
6 Completed Aerosolized Randomized Iloprost Study II (AIR - II) Long-Term Safety, Tolerability, and Clinical Effects of Iloprost Inhalation in Patients With Primary or Secondary Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: Ventavis (Iloprost, BAYQ6256)
7 Recruiting Non-interventional Study on Compliance of Inhaled Treatment With Ventavis in Patient With Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: Iloprost (Ventavis, BAYQ6256)
8 Completed Atorvastatin in Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Interventions: Drug: Atorvastatin;   Drug: Placebo
9 Recruiting Tracking Outcomes and Practice in Pediatric Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention:
10 Recruiting Acute Hemodynamic Effect of Acetazolamide in Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Interventions: Drug: Acetazolamide;   Drug: Placebo
11 Active, not recruiting Electronic Activity Level Monitoring Pilot in Pulmonary Hypertension
Conditions: Pulmonary Hypertension;   Hypertension, Pulmonary
Intervention: Other: Correlation assessment
12 Recruiting EXPERT, EXPosurE Registry RiociguaT in Patients With Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: Riociguat(BAY63-2521)
13 Recruiting Prospective, Non-interventional, Multi-center Post-authorization Safety Study of Riociguat for Chronic Thromboembolic Pulmonary Hypertension (CTEPH )
Condition: Hypertension, Pulmonary
Intervention: Drug: Riociguat (ADEMPAS, BAY63-2521)
14 Active, not recruiting Impact of Multiple Doses of BAY63-2521 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Patients With Interstitial Lung Disease (ILD) Associated Pulmonary Hypertension (PH)
Condition: Hypertension, Pulmonary
Intervention: Drug: Riociguat (Adempas, BAY63-2521)
15 Completed Safety Follow-up Study of Inhaled Iloprost in Patients With Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: Ventavis (Iloprost, BAYQ6256)
16 Terminated Safety of Terbogrel in Patients With Primary Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: Terbogrel
17 Completed Safety and Efficacy of Terbogrel in Patients With Primary Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Interventions: Drug: Terbogrel low dose;   Drug: Terbogrel high dose;   Drug: Placebo
18 Completed Interaction Study in Patients With Pulmonary Hypertension and Stable Treatment of Sildenafil 20 mg TID
Condition: Hypertension, Pulmonary
Intervention: Drug: Riociguat (Adempas, BAY63-2521)
19 No longer available Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Condition: Hypertension, Pulmonary
Intervention: Drug: Adempas (Riociguat, BAY63-2521)
20 Terminated
Has Results
Inhaled Aerosolized Prostacyclin for Pulmonary Hypertension Requiring Inhaled Nitric Oxide
Condition: Pulmonary Hypertension
Intervention: Drug: Inhaled Iloprost

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.